共 12 条
[1]
Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Hideshima,T,Anderson,KC. Nature Reviews Cancer . 2002
[2]
Recent advances in thetreatment of multiple myeloma. Yasui H,Hideshima T,Richardson PG,et al. Current Pharmaceutical Biotechnology . 2006
[3]
Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Miyakoshi,S,Kami,M,Yuji,K,Matsumura,T,Takatoku,M,Sasaki,M,Narimatsu,H,Fujii,T,Kawabata,M,Taniguchi,S,Ozawa,K,Oshimi,K. Blood . 2006
[4]
Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro. Zhou YX,Huang YL,Xu QN,et al. Chinese journal of Cancer . 2002
[5]
Apoptosis induction in HL-60 cells and inhibition of topoisomeraseⅡby triterpene celastrol. agase M,Oto J,Sugiyama S,et al. Bioscience Biotechnology and Biochemistry . 2003
[6]
Natural products in cancer chemotherapy: past, present and future. Mann J. Nature Reviews Cancer . 2002
[7]
Marine natural products as anticancer drugs. Simmons TL,Andrianasolo E,McPhail K,et al. Molecular Cancer Therapeutics . 2005
[8]
Zerumbone a bioactive sesquiterpene,induces G2/M cell cycle arrest and apoptosis in leukemiacells via a Fas-and mitochondria-mediated pathway. Xian M,Ito K,Nakazato T,et al. CancerSci . 2007
[9]
Thalidomide and its derivatives : New promise for multiple myeloma. Weber D. Cancer Control . 2003
[10]
Antitumor agents.Five newagaro-furans,Reissantins A-E,and cytotoxic principles from Reissantia buchana-nii. Chang FR,Hayashi K,Chen IH,et al. Journal of Natural Products . 2003